Neurofibroma, Plexiform Clinical Trial
Official title:
Phase 2 Study of Imatinib in Children With Neurofibromatosis and Airway Tumors
The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy. Funding Source - FDA OOPD
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01362803 -
AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03531814 -
Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials
|
N/A | |
| Active, not recruiting |
NCT03741101 -
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
|
Phase 2 | |
| Not yet recruiting |
NCT06360406 -
Real-World Treatment Study of Koselugo (Selumetinib)
|
||
| Completed |
NCT00076102 -
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
|
Phase 2 | |
| Completed |
NCT00021541 -
R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
|
Phase 2 | |
| Withdrawn |
NCT03027401 -
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
|
||
| Recruiting |
NCT05199376 -
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
|
N/A | |
| Recruiting |
NCT06175637 -
Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs
|
||
| Recruiting |
NCT02390752 -
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
|
Phase 1 |